Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study

Phase Ii Study ◽

High Dose ◽

Delayed Nausea ◽

Cell Transplants ◽

High Dose Melphalan

A Phase II study of153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

American Journal of Hematology ◽

10.1002/ajh.21696 ◽

2010 ◽

pp. NA-NA

Author(s):

Angela Dispenzieri ◽

Gregory A. Wiseman ◽

Martha Q. Lacy ◽

Suzanne R. Hayman ◽

Shaji K. Kumar ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Peripheral Blood ◽

Phase Ii Study ◽

Conditioning Regimen ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan

471: An Aprepitant Containing Regimen Controls the Delayed Nausea and Vomiting Associated with High-dose Melphalan Followed by Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.12.481 ◽

2008 ◽

Vol 14 (2) ◽

pp. 166

Author(s):

T.P. Bechtel ◽

B.S. Crawford ◽

S.M. Gordon ◽

S. Penza ◽

C. Hofmeister ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

High Dose ◽

Delayed Nausea ◽

High Dose Melphalan ◽

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

British Journal of Cancer ◽

10.1054/bjoc.2001.2069 ◽

2001 ◽

Vol 85 (9) ◽

pp. 1240-1246 ◽

Cited By ~ 5

Author(s):

P H Cottu ◽

J M Extra ◽

M Espie ◽

J P Marolleau ◽

A de Roquancourt ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Peripheral Blood ◽

Phase Ii Study ◽

High Dose ◽

Stem Cell Support ◽

Cell Support

A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.08.017 ◽

2016 ◽

Vol 22 (12) ◽

pp. 2165-2171 ◽

Cited By ~ 9

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Peripheral Blood ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan ◽

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Leukemia ◽

10.1038/sj.leu.2403575 ◽

2004 ◽

Vol 19 (1) ◽

pp. 118-125 ◽

Cited By ~ 31

Author(s):

A Dispenzieri ◽

G A Wiseman ◽

M Q Lacy ◽

M R Litzow ◽

P M Anderson ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Peripheral Blood ◽

Phase I Study ◽

Conditioning Regimen ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

Experimental Hematology and Oncology ◽

10.1186/s40164-018-0110-0 ◽

2018 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Henrik Gregersen ◽

Trung Do ◽

Ida Bruun Kristensen ◽

Ulf Christian Frølund ◽

Niels Frost Andersen ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Induction Therapy ◽

Phase Ii Study ◽

High Dose ◽

Newly Diagnosed ◽

Stem Cell Support ◽

High Dose Melphalan ◽

Cell Support

Pegfilgrastim to accelerate neutrophil engraftment following peripheral blood stem cell transplant and reduce the duration of neutropenia, hospitalization, and use of intravenous antibiotics: a phase II study in multiple myeloma and lymphoma and comparison with filgrastim-treated matched controls

Leukemia & Lymphoma ◽

10.3109/10428194.2010.545462 ◽

2011 ◽

Vol 52 (3) ◽

pp. 436-443 ◽

Cited By ~ 9

Author(s):

Luciano Wannesson ◽

François Luthi ◽

Emanuele Zucca ◽

Anne Rosselet-christ ◽

Mauro Baglioni ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Peripheral Blood ◽

Stem Cell Transplant ◽

Phase Ii Study ◽

Cell Transplant ◽

Intravenous Antibiotics ◽

Neutrophil Engraftment

Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704994 ◽

2005 ◽

Vol 35 (12) ◽

pp. 1165-1169 ◽

Cited By ~ 33

Author(s):

M H Jagasia ◽

J P Greer ◽

D S Morgan ◽

S Mineishi ◽

A A Kassim ◽

...

Keyword(s):

Stem Cell ◽

Phase Ii ◽

Peripheral Blood ◽

Stem Cell Transplant ◽

Phase Ii Study ◽

High Dose Chemotherapy ◽

Blood Stem Cell ◽

High Dose ◽

Cell Transplant

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients

European Journal Of Haematology ◽

10.1111/j.1600-0609.2006.00736.x ◽

2006 ◽

Vol 77 (5) ◽

pp. 410-415 ◽

Cited By ~ 30

Author(s):

Massimo Martino ◽

Giulia Praticò ◽

Giuseppe Messina ◽

Giuseppe Irrera ◽

Elisabetta Massara ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan ◽

Cardiomyopathy Following High Dose Melphalan Conditioning Prior to Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma and Primary Amyloidosis

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2010.12.157 ◽

2011 ◽

Vol 17 (2) ◽

pp. S203 ◽

Cited By ~ 1

Author(s):

J.S. Bleeker ◽

M.A. Gertz ◽

P.A. Pellikka ◽

F. Buadi ◽

D. Dingli ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cell Transplantation ◽

Peripheral Blood ◽

High Dose ◽

Primary Amyloidosis ◽

High Dose Melphalan ◽